Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD

NCT00151970 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
128
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Noven Therapeutics

Collaborators